SDGR
Companies
NASDAQ
Schrodinger Inc.
Health Care
$20.88
+$1.76 (+9.12%)
Price Chart
Overview
About SDGR
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Market Cap
$1.6B
Volume
20.9M
Avg. Volume
20.7M
P/E Ratio
-7.2753034
Dividend Yield
0.00%
Employees
844.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Health Information Services
Website
Latest News for SDGR
BofA Downgrades Schrodinger On Slower Drug Discovery Ramp
November 11, 2021
Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI
May 28, 2025
The Good And Bad: Allison Transmission & Schrodinger Inc.
September 21, 2023
RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside?
May 27, 2025
Risk & Correlation Analysis
Market Correlation
1.21
Moderate Correlation
Volatility
High (0.62)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SDGR shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.6B
Volume20.9M
P/E Ratio-7.28
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025